We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALA icon
2076
KALA BIO
KALA
$15.4M
$27K ﹤0.01%
+9
New +$41.8K
SYBX
2077
DELISTED
Synlogic
SYBX
$26K ﹤0.01%
+728
New +$28.3K
MARK
2078
DELISTED
Remark Holdings, Inc.
MARK
$25K ﹤0.01%
+2,533
New +$33K
CBUS icon
2079
Cibus
CBUS
$132M
$23K ﹤0.01%
+216
New +$31.4K
VTGN icon
2080
VistaGen Therapeutics
VTGN
$10.8M
$23K ﹤0.01%
+400
New +$26K
ABTC
2081
American Bitcoin Corp
ABTC
$629M
0
NGD
2082
DELISTED
New Gold Inc
NGD
$22K ﹤0.01%
+14,541
New +$21K
VTVT icon
2083
vTv Therapeutics
VTVT
$134M
$22K ﹤0.01%
553
+205
+59% +$11K
TLMD
2084
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$20K ﹤0.01%
+15,802
New +$31.7K
AVTX icon
2085
Avalo Therapeutics
AVTX
$1.03B
$18K ﹤0.01%
+4
New +$24K
MRKR icon
2086
Marker Therapeutics
MRKR
$25M
$18K ﹤0.01%
1,878
-336
-15% -$4.46K
QUAD icon
2087
Quad
QUAD
$528M
$17K ﹤0.01%
4,161
-13,904
-77% -$56.9K
NEE.PRP
2088
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$17K ﹤0.01%
294
-706
-71% -$38.4K
GNPX icon
2089
Genprex
GNPX
$3.3M
0
KKR.PRC
2090
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
$16K ﹤0.01%
+168
New +$15.6K
AVTR.PRA
2091
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
$16K ﹤0.01%
+126
New +$15.2K
ODT
2092
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$16K ﹤0.01%
+12,108
New +$28.6K
CDTX
2093
DELISTED
Cidara Therapeutics
CDTX
$15K ﹤0.01%
577
+5
+0.9% +$156
SVRA icon
2094
Savara
SVRA
$1.14B
$14K ﹤0.01%
11,268
-16,692
-60% -$19.9K
VISL
2095
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$14K ﹤0.01%
+594
New +$18.6K
YQ
2096
17 Education & Technology Group
YQ
$23.1M
$13K ﹤0.01%
+2,076
New +$26.6K
PCGU
2097
DELISTED
PG&E Corporation
PCGU
$13K ﹤0.01%
+112
New +$12.7K
LPCN icon
2098
Lipocine
LPCN
$17M
$12K ﹤0.01%
689
-644
-48% -$12K
YCBD icon
2099
cbdMD
YCBD
$5.47M
$12K ﹤0.01%
+32
New +$18.6K
BDXB
2100
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$12K ﹤0.01%
+225
New +$11.8K

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.